Results 241 to 250 of about 701,274 (266)

Chronological Trends in Progression-Free, Overall, and Post-Progression Survival in First-Line Therapy for Advanced NSCLC

Journal of Thoracic Oncology, 2019
Marc Buyse, Jacek Rutkowski, Jacek Jassem   +2 more
exaly  

Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas

Neuro-Oncology, 2008
Minesh Mehta, Howard Fine, Lisa Deangelis   +2 more
exaly  

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

Lancet, The, 2004
Jean-Yves Blay, , Ian Judson
exaly  

Correlation of progression-free and post-progression survival with overall survival in advanced colorectal cancer

Annals of Oncology, 2013
Fausto Petrelli, Sandro Barni
exaly  

NEJ026 trial: progression-free survival benefit is not enough

The Lancet Oncology, 2019
openaire   +2 more sources

Valid Analysis of Brain-Specific Progression-Free Survival

JAMA Oncology
Stephanie, Armbruster, Ethan B, Ludmir, Lee-Jen, Wei   +2 more
openaire   +4 more sources

Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer

Lung Cancer, 2013
Massimo Di Maio, Katsuyuki Hotta, Christian Manegold   +2 more
exaly  

BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study

Gynecologic Oncology, 2016
Toby Johnson, Michael Friedlander, CHÜN-FANG Xu   +2 more
exaly  

Pricing a Year of Progression-Free Survival

JAMA Dermatology, 2019
Sarah S P, DiMagno, Ezekiel J, Emanuel
openaire   +2 more sources

Estimating progression-free survival in patients with glioblastoma using routinely collected data

Journal of Neuro-Oncology, 2017
Matt Williams, Williams Matt
exaly